Malzix GB Tablet is a combination medication containing Gabapentin 300 mg and Methylcobalamin 500 mcg, formulated for the management of neuropathic pain and peripheral neuropathies. Gabapentin, an anticonvulsant agent, modulates neuronal excitability by inhibiting voltage-gated calcium channels, thereby reducing abnormal nerve firing and alleviating neuropathic pain symptoms. Methylcobalamin, an active form of vitamin B12, plays a crucial role in nerve regeneration and repair by promoting myelin sheath synthesis and enhancing neuronal metabolism. This synergistic combination is particularly beneficial in conditions such as diabetic neuropathy, postherpetic neuralgia, and other nerve-related disorders where both pain relief and nerve healing are desired. Malzix GB Tablet is typically prescribed as part of a comprehensive treatment plan, with dosage tailored according to the severity of symptoms and patient response. It is generally well tolerated; however, patients should be monitored for potential side effects such as dizziness, somnolence, or gastrointestinal disturbances. Caution is advised in individuals with renal impairment or hypersensitivity to any component. Malzix GB Tablet offers an effective therapeutic option for improving quality of life in patients suffering from chronic neuropathic conditions by addressing both symptomatic pain and underlying nerve health.